Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
4/17/25 06:10 | 4/15/25 | RNXT | Health | Drug | Pharmaceutical Preparations | Agah Ramtin | CA | DO | Chief Me | 5 | P.d | 76 | 0.5739 | 0 | 132 | 13 | 1,113 | D | ||||||||||||||
4/16/25 06:08 | 4/15/25 | RNXT | Health | Drug | Pharmaceutical Preparations | Bagai Shaun | CA | DO | CEO | 4 | P.d | 23 | 0.3420 | 0 | 68 | 27 | 320 | D | ||||||||||||||
4/10/25 19:02 | 4/8/25 | RNXT | Health | Drug | Pharmaceutical Preparations | Kocak Ron | CA | O | VP Contr | 1 | P.m | 10 | 0.7948 | 0 | 13 | 13 | D | |||||||||||||||
4/9/25 21:30 | 4/8/25 | RNXT | Health | Drug | Pharmaceutical Preparations | Marton Laurence | CA | D | 2 | P.d | 10 | 0.5047 | 0 | 20 | 80 | 46 | D | |||||||||||||||
1/30/24 19:00 | 1/26/24 | RNXT | Health | Drug | Pharmaceutical Preparations | Spiegel Robert J. | CA | D | 1 | P.d | 0 | 0.00 | 0 | 41 | 41 | D | ||||||||||||||||
1/30/24 18:30 | 1/26/24 | RNXT | Health | Drug | Pharmaceutical Preparations | Macfarlane K. Angela | CA | D | 1 | P.d | 0 | 0.00 | 0 | 41 | 41 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |